Calcipressin-1 (RCAN1) Peptide

Product Graph
175.5€ (100 µg)

Por favor contáctenos para obtener información detallada sobre el precio y disponibilidad.

935106861
info@markelab.com
name
Calcipressin-1 (RCAN1) Peptide
category
Proteins and Peptides
provider
Abbexa
reference
abx616496
tested applications
P-ELISA

Description

Calcipressin-1 (RCAN1) Peptide is a synthetic peptide.

Documents del producto

Instrucciones
Data sheet
Descargar

Product specifications

Category
Proteins and Peptides
Immunogen Target
Calcipressin-1 (RCAN1)
Host
Synthetic
Recommended Dilution
BL (predicted): 0.5 mg/ml. Optimal dilutions/concentrations should be determined by the end user.
Conjugation
Unconjugated
Observed MW
Sequence Fragment: Internal region: C-HIGSSHLAPPNPD
Size 1
100 µg
Form
Lyophilized Reconstitute in deionized water.
Tested Applications
P-ELISA
Buffer
Prior to lyophilization: Deionized water.
Availability
Shipped within 5-10 working days.
Storage
Aliquot and store at -20°C. Avoid repeated freeze/thaw cycles.
Dry Ice
No
Gene ID
1827, 54720, 266766
NCBI Accession
NP_004405.3, NP_981962.1, NP_981963.1
Background
Protein RCAN1
Note
This product is for research use only.   Not for human consumption, cosmetic, therapeutic or diagnostic use.

Descripción

Related Products

EH11742

Human RCAN1 (Calcipressin-1) ELISA Kit

Ver Producto
FNab07201

RCAN1 antibody

Inhibits calcineurin-dependent transcriptional responses by binding to the catalytic domain of calcineurin A. Could play a role during central nervous system development.

Ver Producto
abx004072

Calcipressin-1 (RCAN1) Antibody

RCAN1 Antibody is a Rabbit Polyclonal antibody against RCAN1. The protein encoded by this gene interacts with calcineurin A and inhibits calcineurin-dependent signaling pathways, possibly affecting central nervous system development. This gene is located in the minimal candidate region for the Down syndrome phenotype, and is overexpressed in the brain of Down syndrome fetuses. Chronic overexpression of this gene may lead to neurofibrillary tangles such as those associated with Alzheimer disease. Alternative splicing results in multiple transcript variants.

Ver Producto